Newsmeme!
Discover News you didn't know existed
NEW YORK----Reportlinker.com announces that a new market research report related to the Diagnostic equipment industry is available in its catalogue.
DUBLIN, Ireland----Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Enabling Oncology Diagnostics: Predictive Biomarkers Based on Genes, Proteins, and Pathways" to their offering.
Chiome Bioscience and Chugai Pharmaceutical Co., Ltd. have signed a joint research agreement for the generation of monoclonal antibodies against multiple target proteins chosen by Chugai Pharmaceutical.
Research and Markets ( http://www.researchandmarkets.com/research/dedabf/its_all_about_the ) has announced the addition of Decision Resources, Inc.'s new report "It's All About the Biomarkers: How 2008's Biomarker-Based Partnering Is Driving Personalized Medicine" to their offering.
DUBLIN, Ireland----Research and Markets has announced the addition of Decision Resources, Inc.'s new report "It's All About the Biomarkers: How 2008's Biomarker-Based Partnering Is Driving Personalized Medicine" to their offering.
DUBLIN, Ireland----Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Emerging Blockbusters: 2009's Most Promising Drugs and the Future of the Blockbuster Model" to their offering.
Research and Markets ( http://www.researchandmarkets.com/research/94f4d3/autoimmune_disease ) has announced the addition of Decision Resources, Inc.'s new report "AUTOIMMUNE DISEASE SERIES: Strategies for Success in the Challenging Sjögren's Syndrome Market" to their offering.
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) and Roche (SWX: ROG) announced today the formation of a strategic alliance to discover, develop, and commercialize small-molecule drugs targeting a novel family of ion channels that are critical to immune cell function, known as calcium release-activated calcium modulator (CRACM) channels. In preclinical models, the CRACM inhibitors discovered by Synta ...
LEXINGTON, Mass.----Synta Pharmaceuticals Corp. and Roche announced today the formation of a strategic alliance to discover, develop, and commercialize small-molecule drugs targeting a novel family of ion channels that are critical to immune cell function, known as calcium release-activated calcium modulator channels.
NEW YORK----Reportlinker.com announces that a new market research report related to the Laboratory equipment industry is available in its catalogue.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |